Mark Munson

Co-Founder and Vice President of Medicinal Chemistry, Sionna Therapeutics

Boston, Massachusetts

About

Male

Mark Munson is the Co-Founder and Vice President of Medicinal Chemistry of Sionna Therapeutics. He previously worked at Sanofi as a Head of Medicinal Chemistry, in North America. Mark Munson attended Macalester College.

Experience

Sionna Therapeutics

Co-Founder and Vice President of Medicinal Chemistry

View →

Growth62Natick, Massachusetts, United StatesBiotech/Pharma · Biotechnology

Education

University of Minnesota · Doctor of Philosophy, Chemistry
1988 – 1993
Macalester College · Bachelor of Science, Chemistry
1984 – 1988

Headlines from Google News. Social posts load from the platform only when you open a tab.

SION Stock Price and Chart — NASDAQ:SION
TradingView · Oct 12
Member Spotlight: Sionna Therapeutics
Massachusetts Biotechnology Council · Mar 4
Vertex Pharma Challenger Sionna Secures $191M in IPO Cash for Cystic Fibrosis Pipeline
MedCity News · Feb 9
Odyssey, Sionna join band of biotechs ready to brave thawing IPO waters in 2025
Fierce Biotech · Jan 21
Sionna Therapeutics Launches with $111 Million Series B Financing
citybiz · Apr 19

People at Sionna Therapeutics

Greg Hurlbut

Co-Founder and SVP Head of Research

Michael Cloonan

President and Chief Executive Officer

Bruce Booth

Investor

Data from: crunchbase